Europe Brain Cancer Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 161
Report Code: TIPRE00025898
Category: Life Sciences
Europe Brain Cancer Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Brain Cancer Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Brain Cancer Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Brain Cancer Diagnostics Market Regional Analysis

6.2 Europe Brain Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Brain Cancer Diagnostics Market Forecast Analysis

7. Europe Brain Cancer Diagnostics Market Analysis – by Diagnostic Type

7.1 Imaging Test
  • 7.1.1 Overview
  • 7.1.2 Imaging Test: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Lumbar Puncture
  • 7.2.1 Overview
  • 7.2.2 Lumbar Puncture: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Biopsy
  • 7.3.1 Overview
  • 7.3.2 Biopsy: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Molecular Testing
  • 7.4.1 Overview
  • 7.4.2 Molecular Testing: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Brain Cancer Diagnostics Market Analysis – by Cancer Type

8.1 Acoustic Neuroma
  • 8.1.1 Overview
  • 8.1.2 Acoustic Neuroma: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Astrocytoma
  • 8.2.1 Overview
  • 8.2.2 Astrocytoma: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Craniopharyngiomas
  • 8.3.1 Overview
  • 8.3.2 Craniopharyngiomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Ganglioneuromas
  • 8.4.1 Overview
  • 8.4.2 Ganglioneuromas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Glioblastoma Multiforme
  • 8.5.1 Overview
  • 8.5.2 Glioblastoma Multiforme: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Meningiomas
  • 8.6.1 Overview
  • 8.6.2 Meningiomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.7 Ependymomas
  • 8.7.1 Overview
  • 8.7.2 Ependymomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Brain Cancer Diagnostics Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Specialty Clinics
  • 9.2.1 Overview
  • 9.2.2 Specialty Clinics: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Ambulatory Surgical Centers: Europe Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Brain Cancer Diagnostics Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Brain Cancer Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Europe Brain Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 UK: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.1.2 UK: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.1.3 UK: Europe Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.2.2 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.2.3 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.2.1.3 France: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 France: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.3.2 France: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.3.3 France: Europe Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.4.2 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.4.3 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.5.2 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.5.3 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.2.1.6.2 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.2.1.6.3 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Siemens Healthineers A
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GE Healthcare
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Biocept, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Koninklijke Philips N.V
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Canon Medical Systems
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Hitachi, Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Neusoft Medical Systems
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Brain Cancer Diagnostics Market

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers A
  • GE Healthcare
  • Biocept, Inc.
  • Koninklijke Philips N.V
  • Canon Medical Systems
  • Hitachi, Ltd.
  • Neusoft Medical Systems

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)